Results 1 to 10 of about 4,224,042 (268)

Incorporating the Detection of Single Nucleotide Polymorphisms Associated With Invasive Aspergillosis Into the Clinic

Frontiers in Cellular and Infection Microbiology, 2022
Exposure to fungi is inevitable, yet only a small number of patients with significant clinical risk develop invasive aspergillosis (IA). While timing of exposure in relation to immune status, environmental and occupational factors will influence the ...
P. Lewis White, Jessica S. Price
doaj   +1 more source

GP assessment of unmet need in a complex multimorbid population using a data-driven and clinical triage system: a prospective cohort study

BJGP Open, 2023
Background: Patients with unmet healthcare needs are more likely to access unscheduled care. Identifying these patients through data-driven and clinical risk stratification for active case management in primary care can help address patient need and ...
Emma Parry, Kamran Ahmed, Simon Evans, Elizabeth Guest, Vijay Klaire, Abdool Koodaruth, Prasadika Labutale, Dawn Matthews, Jonathan Lampitt, Gillian Pickavance, Mona Sidhu, Kate Warren, Baldev Singh   +12 more
doaj   +1 more source

Clinical risk in remote consultations in general practice: findings from in-COVID-19 pandemic qualitative research

BJGP Open, 2022
Background: The COVID-19 pandemic-related rise in remote consulting raises questions about the nature and type of risks in remote general practice.
Rebecca Rosen, Sietse Wieringa, Trisha Greenhalgh, Claudia Leone, Sarah Rybczynska-Bunt, Gemma Hughes, Lucy Moore, Sara E Shaw, Joseph Wherton, Richard Byng   +9 more
doaj   +1 more source

Managing clinical risk [PDF]

BMJ, 1994
The number of negligence claims made against health authorities rose dramatically during the 1980s.1 Since Crown Indemnity was introduced in 1990 the responsibility for meeting these claims has shifted from defence organisations to health authorities and NHS trusts.
J, Mant, A, Gatherer
openaire   +2 more sources

Clinical Pharmacology and Vascular Risk [PDF]

The Open Neurology Journal, 2010
Pharmacological treatment and several drugs of abuse have been associated with ischemic heart disease (IHD) and cerebrovascular diseases (CVD). However, there is a paucity of data on the independent risk of vascular disease (VD) associated with pharmacological treatment and no controlled trials demonstrating a reduction in risk with abstinence.
Silvestrelli, G., Corea, F., Micheli, S., Lanari, A.   +3 more
openaire   +2 more sources

Risk communication in the clinical consultation [PDF]

Clinical Medicine, 2005
Modern healthcare and modern societies are facing up to the need for greater engagement of patients in treatment decisions. Shared and informed decision-making is replacing traditional paternalistic approaches to decisions; health policy both reflects and drives these changes.
Thomson R, Edwards A, Grey J
openaire   +2 more sources

Behavioral problems in psychotic, clinically high-risk, and non-psychotic adolescent patients

Annals of General Psychiatry, 2022
Background A growing body of research provides evidence for social and behavioral problems observed among adolescents with psychosis and also as precursors of vulnerability to psychosis, long before the illness onset, especially in females patients.
Chiara Rogantini, Livio Provenzi, Renato Borgatti, Martina Mensi, Clinical High Risk State For Psychosis Research Group   +4 more
doaj   +1 more source

Clinical risk analysis of the patient’s path in an Advanced Radiotherapy Center (A.R.C.) through F.M.E.A. method

Journal of Biomedical Practitioners, 2019
Starting from the increasing requirement of efficient access to healthcare, the study aims to assess the current standard procedures in order to optimize safety and quality.
Claudio Pobbiati, Massimo Monturano, Andrea Vavassori, Marianna Gerardi, Massimo Sarra Fiore, Elena Rondi, Enrica Borghetti, Fabio Castellini, Valerio Scroffi, Camilla Arrobbio, Fabiana Castelluccia, Valeria Gandellini, Saverio Greco, Assuntina Leppa, Barbara Alicja Jereczek-Fossa   +14 more
doaj   +1 more source

Should a Multigene Signature be Used in all Luminal Early Breast Cancers

Frontiers in Oncology, 2019
Background: Multigene signatures refine the risk of recurrence and guide adjuvant chemotherapy decision in luminal breast cancers. The decision to perform the assay is highly variable among oncologists. In order to guide the appropriate clinical group in
Nawale Hajjaji, Nawale Hajjaji, Yves Marie Robin, Yves Marie Robin, Jacques Bonneterre, Jacques Bonneterre   +5 more
doaj   +1 more source

Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers

Drugs in R&D, 2023
Background and Objective Tucatinib is a selective tyrosine kinase inhibitor of the human epidermal growth factor receptor 2 (HER2) approved to treat metastatic HER2-positive breast and colorectal cancers.
Ariel R. Topletz-Erickson, JoAl G. Mayor, Hsu-Tai Liu, Layth I. Abdulrasool, Christopher J. Endres   +4 more
doaj   +1 more source